“Adaptive pathways” to drug authorisation: adapting to industry?

    loading  Checking for direct PDF access through Ovid

Abstract

Evidence for benefits to patients and public health of adaptive pathways is lacking or contradictory, say Courtney Davis and colleagues

Related Topics

    loading  Loading Related Articles